Estimation of Effectiveness of Lymphoma Treatment with Damage of Peripheral Lymph Nodes Using Ultrasonic Study with Contrast Enhancement
E. V. Kovaleva,
E. A. Gudilina,
T. Yu. Danzanova,
G. T. Sinyukova,
G. F. Allahverdieva,
P. I. Lepedatu https://doi.org/10.37174/2587-7593-2020-3-3-35-43
Abstract
Purpose: To evaluate the possibilities of ultrasound examination with contrast enhancement (CEUS) in assessing the effectiveness of treatment of patients with specific lesions of peripheral lymph nodes with lymphoproliferative lesions.
Material and methods: To assess the capabilities of CEUS in assessing the effectiveness of treatment, a study was carried out for 15 patients with lesions of peripheral lymph nodes in lymphoma in dynamics before the treatment and after 2 or 3 courses of chemotherapy using a contrast agent SonoVue® in a volume of 4.8 ml. The results of the study were analyzed and compared with traditional ultrasound techniques. Ultrasound examination was performed using Siemens Acuson S2000 and Philips Affiniti 70 devices with high-frequency linear transducers from 5 to 12 MHz.
Results: CEUS revealed a significant increase in the TTP parameter from 27 ± 12 s to 36 ± 13 s (p = 0.0496) and a significant decrease in the PI parameter from 9 ± 5 dB to 4 ± 3dB (p = 0.00047).
Conclusions: CEUS at any stage of the treatment seems to be promising since it allows diagnosing of structural changes in the affected lymph nodes even after one cycle of chemotherapy.
About the Authors
E. V. Kovaleva
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
E. A. Gudilina
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
T. Yu. Danzanova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
G. T. Sinyukova
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
G. F. Allahverdieva
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
P. I. Lepedatu
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests: Not declared.
Russian Federation
24 Kashirskoye Highway, Moscow, 115478.
Competing Interests: Not declared.
References
1. Kovaleva E.V, Danzanova TYu, Sinyukova GT, et al. Successful experience in the use of ultrasound elastography in the approach to preliminary intermediate assessment of the effectiveness of treatment of patients with Hodgkin's lymphoma. Oncohematology. 2019;14(4):40-6. (In Russ.) DOI: 10.17650/1818-8346-2019-14-4-40-46.
2. Kovaleva EV, Danzanova TYu, Sinyukova GT, et al. Successful experience in the use of ultrasound elastography in the differential diagnosis of altered superficial lymph nodes in lymphoma and metastases of solid tumors. Oncohematology. 2020;15(2):25-31. (In Russ.) DOI: 10.17650/1818-8346-2020-15-2-00-00.
3. Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver — update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Medicine. 2013(34):11-29. DOI: 10.1055/s-0032-1325499.
4. Sidhu PS, Cantisani V, Dietrich CF, et al. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall in Medicine. 2018(39):e2-e44. DOI: 10.1055/a-0586-1107.
5. Cui QL, Yin SS, Fan ZH, et al. Diagnostic Value of Contrast-Enhanced Ultrasonography and TimeIntensity Curve in Differential Diagnosis of Cervical Metastatic and Tuberculous Lymph Nodes. J Ultrasound Med. 2018;37(1):83-92. DOI: 10.1002/jum.14311.
6. Xin L, Yan Z, Zhang X, et al. Parameters for contrast-enhanced ultrasound (CEUS) of enlarged superficial lymph nodes for the evaluation of therapeutic response in lymphoma: a preliminary study. Med Sci Monitor. 2017(23):5430-8. DOI: 10.12659/msm.907293.
7. Du W, Ling W, Ma X, et al. Contrast-enhanced ultrasound in the therapeutic assessment of diffuse large B-cell lymphoma: A case report. Oncology Letters. 2017;14(4):4593-8. DOI: 10.3892/ol.2017.6758.
8. Cao X, Xue J, Zhao B. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer. Ultrasound Med Biol. 2012;38(12):2065-71. DOI: 10.1016/j.ultrasmedbio.2012.07.027.
9. Peng C, Liu LZ, Zheng W, et al. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy? Eur J Radiol. 2016;85(11):2111-8. DOI: 10.1016/j.ejrad.2016.09.025.
10. Ueda N, Nagira H, Sannomiya N, et al. Contrast-enhanced ultrasonography in evaluation of the therapeutic effect of chemotherapy for patients with liver metastases. Yonago Acta Medica. 2016;59(4):255-61.
Review
For citations:
Kovaleva E.V., Gudilina E.A., Danzanova T.Yu., Sinyukova G.T., Allahverdieva G.F., Lepedatu P.I. Estimation of Effectiveness of Lymphoma Treatment with Damage of Peripheral Lymph Nodes Using Ultrasonic Study with Contrast Enhancement. Journal of oncology: diagnostic radiology and radiotherapy. 2020;3(3):35-43. (In Russ.) https://doi.org/10.37174/2587-7593-2020-3-3-35-43
Views:
518
Email this article 